Heyu Biological Technology (OTCMKTS:HYBT) and Integer (NYSE:ITGR) Head-To-Head Contrast

Integer (NYSE:ITGR) and Heyu Biological Technology (OTCMKTS:HYBT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Integer and Heyu Biological Technology, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0	1	6	0	2.86
Heyu Biological Technology	0	0	0	0	N/A

Integer presently has a consensus price target of $138.71, suggesting a potential upside of 6.35%. Given Integer’s higher possible upside, equities research analysts plainly believe Integer is more favorable than Heyu Biological Technology.

Profitability

This table compares Integer and Heyu Biological Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	6.31%	11.48%	5.79%
Heyu Biological Technology	-453.55%	-6.43%	-4.43%

Volatility & Risk

Integer has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Heyu Biological Technology has a beta of -17.74, meaning that its share price is 1,874% less volatile than the S&P 500.

Earnings and Valuation

This table compares Integer and Heyu Biological Technology”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.67 billion	2.62	$90.65 million	$2.89	45.13
Heyu Biological Technology	$80,000.00	300.06	-$270,000.00	N/A	N/A

Integer has higher revenue and earnings than Heyu Biological Technology.

Institutional and Insider Ownership

99.3% of Integer shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 89.2% of Heyu Biological Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Integer beats Heyu Biological Technology on 9 of the 11 factors compared between the two stocks.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

About Heyu Biological Technology

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.